Iðjuþjálfinn - 2021, Side 22

1. tölublað 202122
Heimildir:
Blease, C. R., Lilienfeld, S. O. og Kelley, J. M. (2016). Evidence-based practice and
psychological treatments: The imperatives of informed consent. Frontiers in
Psychology, 7. https://doi.org/10.3389/fpsyg.2016.01170
Chesney, E., Goodwin, G. M. og Fazel, S. (2014). Risks of all-cause and suicide
mortality in mental disorders: A meta-review. World Psychiatry, 13(2), 153-
160. https://doi.org/10.1002/wps.20128
Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., Coghill,
D., Zhang, Y., Hazell, P., Leucht, S., Cuijpers, P., Pu, J., Cohen, D., Ravindran,
A., Liu, Y., Michael, K., Yang, L., Liu, L. og Xie, P. (2016). Comparative efficacy
and tolerability of antidepressants for major depressive disorder in children
and adolescents: A network meta-analysis. The Lancet, 388(10047), 881-890.
https://doi.org/10.1016/S0140-6736(16)30385-3
El-Mallakh, R. S., Gao, Y. og Roberts, R. J. (2011). Tardive dysphoria: The role
of long term antidepressant use in-inducing chronic depression. Medical
Hypotheses, 76(6), 769-773. https://doi.org/10.1016/j.mehy.2011.01.020
Gardner, D. M. (2014). Competent psychopharmacology. The Canadian Journal of
Psychiatry, 59(8), 406-411. https://doi.org/10.1177/070674371405900802
Healy, D., Le Noury, J. og Mangin, D. (2018). Enduring sexual dysfunction after
treatment with antidepressants, 5-reductase inhibitors and isotretinoin: 300
cases. The International Journal of Risk & Safety in Medicine, 29(3-4), 125-134.
https://doi.org/10.3233/JRS-180744
Kavanagh, E., Cahill, J., Arbuckle, M., Lenet, A., Subramanyam, K., Winchel,
R.,Nossel, I., DeSilva, R., Caravella, R., Ackerman, M., Park, H. og Ross, D.
(2017). Psychopharmacology prescribing workshops: A novel method for
teaching psychiatry residents how to talk to patients about medications.
Academic Psychiatry, 41(4), 491-496. https://doi.org/10.1007/s40596-017-
0662-z
KPMG. (2018). Þróun örorku. https://www.stjornarradid.is/lisalib/getfile.
aspx?itemid=
3dec44ec-748b-11e8-9429-005056bc4d74
Lanning, R. K., Zai C. C. og Müller, D. J. (2016). Pharmacogenetics of tardive
dyskinesia: An updated review of the literature. Pharmacogenomics, 17(12).
https://doi.org/10.2217/pgs.16.26
Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C. og
Abi-Jaoude, E. (2015). Restoring study 329: Efficacy and harms of paroxetine
and imipramine in treatment of major depression in adolescence. BMJ, 351,
1-16. https://doi.org/10.1136/bmj.h4320
Leifur Bárðarson, Laura Sch. Thorsteinsson, Salbjörg Bjarnadóttir og Sigríður
Egilsdóttir. (2016). Úttekt – sjálfstætt starfandi geðlæknar, mat á gæðum og
öryggi þjónustu. Embætti landlæknis.
Lyfjateymi Embættis landlæknis. (2017). Leiðbeiningar um góða starfshætti lækna
við ávísun lyfja. https://www.landlaeknir.is/um-embaettid/greinar/grein/
item31883/leidbeiningar-um-goda-starfshaetti-laekna-vid-avisun-lyfja
Mannréttindaráð Sameinuðu þjóðanna. (2017). Report of the Special Rapporteur
on the right of everyone to the enjoyment of the highest attainable standard
of physical and mental health, A/HRC/35/21. http://www.refworld.org/
docid/593947e14.html
Morrison, P., Meehan, T. og Stomski, N. J. (2015). Living with antipsychotic med-
ication side-effects: The experience of Australian mental health consumers.
International Journal of Mental Health Nursing, 24(3), 253-261. https://doi.
org/10.1111/inm.12110
NOMESCO. (2017). Health statistics for the Nordic countries 2017. Nordic Medico-
-Statistical Committee.
OECD. (2017). Health at a glance 2017: OECD indicators. https://doi.org/10.1787/
health_glance-2017-en
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M. og Cohen, D. (2017). Discontinuing
psychiatric medications: A survey of long-term users. Psychiatric Services,
68(12), 1232-1238. https://doi.org/10.1176/appi.ps.201700070
Patten, S. B. (2015). Medical models and metaphors for depression. Epidem-
iology and Psychiatric Sciences, 24(4), 303-308. https://doi.org/10.1017/
S2045796015000153
Townsend, E. A. og Polatajko, H. J. (2007). Enabling occupation II: Advancing
an occupational therapy vision for health, well-being, & justice through
occupation. CAOT Publications ACE.
Tryggingastofnun ríkisins. (2016). Ársskýrsla og staðtölur Tryggingastofnunar
2015. https://indd.adobe.com/view/a1f3a048-adc0-4225-a090-
58f73af98a90
Tyrer, P. og Kendall, T. (2009). The spurious advance of antipsychotic drug
therapy. The Lancet, 373(9657), 4-5. https://doi.org/10.1016/S0140-
6736(08)61765-1
World Health Organization. (2017). Depression and other common mental
disorders: Global health estimates.
Wunderink, L., Nieboer, R., Wiersma, D., Sytema, S. og Nienhuis, F. (2014). 5:30
pm recovery in remitted first-episode psychosis at 7 years of follow-up
of an early dose reduction/discontinuation or maintenance treatment
strategy. Schizophrenia Research, 153, S67. https://doi.org/10.1016/S0920-
9964(14)70215-4
í Hugarafli og styðja einstaklinga til að fá auknar upplýsingar
frá fagaðilum sínum um geðlyf. Við getum verið til staðar fyrir
fólk ef það vill minnka eða hætta á geðlyfjum og stutt það við
að koma þeim óskum á framfæri við þann fagaðila sem ávísaði
þeim geðlyfjunum. Í þeim samtölum er gjarnan verulegt
valdaójafnvægi þar sem hallar á einstaklinginn samanborið við
fagaðilann, og þar gæti stuðningur iðjuþjálfa reynst veigamikill.
Geðlyf snerta okkur öll með einum eða öðrum hætti. Tökum þátt
í umræðunni, stuðlum að bættum starfsháttum og að mann-
réttindi fólks sem tekst á við andlegar áskoranir séu virt að fullu.